Changes in Polypharmacy and Psychotropic Medication Use After Diagnosis of Major Neurocognitive Disorders: A Population-based Study in Québec, Canada.

Maltais, Annie; Simard, Marc; Vedel, Isabelle; Sirois, Caroline

Maltais, Annie; Simard, Marc; Vedel, Isabelle; Sirois, Caroline.

Afiliación

Maltais A; Department of Social and Preventive Medicine, Faculty of Medicine, Laval University.
Simard M; Quebec Center of Excellence on Aging, Research Center of the CHU of Quebec.
Vedel I; Department of Social and Preventive Medicine, Faculty of Medicine, Laval University.
Sirois C; Quebec Center of Excellence on Aging, Research Center of the CHU of Quebec.

Alzheimer Dis Assoc Disord ; 36(3): 222-229, 2022.

Article en En | MEDLINE | ID: mdl-35661072

Asunto(s)

Antipsicóticos; Polifarmacia; Anciano; Antidepresivos/uso terapéutico; Antipsicóticos/uso terapéutico; Antagonistas Colinérgicos/uso terapéutico; Estudios de Cohortes; Humanos; Trastornos Neurocognitivos/tratamiento farmacológico; Psicotrópicos/uso terapéutico; Quebec/epidemiología

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antipsicóticos / Polifarmacia Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Humans País/Región como asunto: America do norte Idioma: En Revista: Alzheimer Dis Assoc Disord Asunto de la revista: NEUROLOGIA / PSIQUIATRIA Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google